Pfizer Inc. | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
51,584
49,605
48,851
52,824
52,546
53,647
Cost of Goods Sold (COGS) incl. D&A
13,954
13,310
13,157
15,954
15,789
16,008
Gross Income
37,630
36,295
35,694
36,870
36,757
37,639
SG&A Expense
20,742
22,266
22,398
22,596
22,332
22,350
EBIT
16,888
14,029
-
14,274
14,425
15,289
Unusual Expense
803
2,094
3,969
6,654
2,596
3,622
Non Operating Income/Expense
642
1,240
321
1,447
1,355
1,201
Interest Expense
1,414
1,360
1,199
1,186
1,270
1,316
Pretax Income
15,716
12,240
8,965
8,351
12,305
11,885
Income Tax
4,306
3,121
1,990
1,122
9,048
706
Consolidated Net Income
11,410
9,119
6,975
7,229
21,353
11,179
Net Income
11,380
9,087
6,949
7,198
21,306
11,143
Net Income After Extraordinaries
757
9,039
6,938
7,181
21,304
11,133
Net Income Available to Common
11,647
9,079
6,965
7,214
21,304
11,152
EPS (Basic)
3.19
1.42
1.11
1.17
3.52
1.87
Basic Shares Outstanding
6,813
6,346
6,176
6,089
5,970
5,872
EPS (Diluted)
3.19
1.42
1.11
1.17
3.52
1.87
Diluted Shares Outstanding
6,895
6,424
6,257
6,159
6,058
5,977
EBITDA
23,298
19,566
18,453
20,031
20,694
21,673
Non-Operating Interest Income
403
425
471
470
391
333
Minority Interest Expense
30
32
26
31
47
36
Equity in Affiliates (Pretax)
-
-
45
-
-
-
Preferred Dividends
2
1
1
1
1
1
About Pfizer
View Profile
